Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in NERV — Minerva Neurosciences, Inc.

CIK 1273087 NEW YORK, NY
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,961,491
-$1,305,962 QoQ
Shares Held
533,602
-24.7% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 58 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. NERV ranks #198 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 468,410 $232,673,299
2 INSM
INSMED Inc
 2,048,005 $218,358,293
3 APGE
Apogee Therapeutics, Inc.
 1,491,404 $197,954,052
4 JAZZ
Jazz Pharmaceuticals plc
 763,880 $184,072,163
5 ONC
BeOne Medicines Ltd.
 543,323 $154,830,755
6 AXSM
Axsome Therapeutics, Inc.
 556,088 $136,113,659
7 BMRN
Biomarin Pharmaceutical Inc
 2,071,816 $118,549,311
8 REGN
Regeneron Pharmaceuticals, Inc.
 165,120 $102,958,924

All Filings in NERV

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,961,491 533,602
2026-03-31 $4,267,453 708,291
2025-12-31 $554,402 137,911
2022-12-31 $45,920 28,881
2022-09-30 $263,608 28,560
2022-06-30 $263,595 79,636
2022-03-31 $654,103 788,077
2021-12-31 $640,317 799,398
2021-09-30 $1,356,192 779,421
2021-06-30 $3,003,110 1,294,444
2021-03-31 $1,669,074 571,601
2020-12-31 $951,303 406,540
2020-09-30 $255,090 80,217
2020-06-30 $93,047 25,775
2020-03-31 $4,596,540 763,545